Exacerbation of experimental autoimmune encephalomyelitis in P2X 7R-/- mice: Evidence for loss of apoptotic activity in lymphocytes

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 3115-3126

  Chen, Laufen ^a   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; LIPOCORTIN 5; NITRIC OXIDE; PROPIDIUM IODIDE; PURINE P2X7 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL PROLIFERATION; CLINICAL FEATURE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENOTYPE; HOMEOSTASIS; INFLAMMATION; LYMPH NODE CELL; LYMPHOCYTE CULTURE; MACROPHAGE; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION CHIMERA; RECEPTOR INTRINSIC ACTIVITY; SPLEEN CELL;

EID: 33644535464     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.3115     Document Type: Article

References (76)

1. Burnstock, G., and M. Williams. 2000. P2 purinergic receptors: modulation of cell function and therapeutic potential. J. Pharmacol Exp. Ther. 295: 862-869.
2. Surprenant, A., F. Rassendren, E. Kawashima, R. A. North, and G. Buell. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738.
3. Chessell, I. P., J. Simon, A. D. Hibell, A. D. Michel, E. A. Barnard, and P. P. Humphrey. 1998. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett. 439: 26-30.
4. Smart, M. L., B. Gu, R. G. Panchal, J. Wiley, B. Cromer, D. A. Williams, and S. Petrou. 2003. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278: 8853-8860.
5. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97: 587-600.
6. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1 β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
7. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1 β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159: 1451-1458.
8. Suzuki, T., I, Hide, K. Ido, S. Kohsaka, K. Inoue, and Y. Nakata. 2004. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24: 1-7.
9. Kucher, B. M., and J. T. Neary. 2005. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-α release in lipopolysaccharide-stimulated astrocytes. J Neurochem. 92: 525-535.
10. 7 ATP receptor. J. Biol Chem. 274: 33206-33208.
11. lck, MAP kinases, and transcription factors AP-I and NF-κB. J. Biol. Chem. 278: 1549-1560.
12. Chiozzi, P., J. M. Sanz, D. Ferrari, S. Falzoni, A. Aleotti, G. N. Buell, G. Collo, and F. Di Virgilio. 1997. Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J. Cell Biol. 138: 697-706.
13. Di Virgilio, F., S. Falzoni, P. Chiozzi, J. M. Sanz, D. Ferrari, and G. N. Buell. 1999. ATP receptors and giant cell formation. J. Leukocyte Biol. 66: 723-726.
14. Lammas, D. A., C. Stober, C. J. Harvey, N. Kendrick, S. Panchalingam, and D. S. Kumararatne. 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7: 433-444.
15. Coutinho-Silva, R., J. L. Perfettini, P. M. Persechini, A. Dautry-Varsat, and D. M. Ojcius. 2001. Modulation of P2Z/P2X(7) receptor activity in macrophages infected with Chlamydia psittaci. Am. J. Physiol 280: C81-C89.
16. Kusner, D. J., and J. Adams, 2000. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol. 164: 379-388.
17. Hu, Y., P. L. Fisette, L. C. Denlinger, A. G. Guadarrama, J. A. Sommer, R. A. Proctor, and P. J. Bertics. 1998. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem. 273: 27170-27175.
18. Gendron, F. P., M. Chalimoniuk, J. Strosznajder, S. Shen, F. A. Gonzalez, G. A. Weisman, and G. Y. Sun. 2003. P2X7 nucleotide receptor activation enhances IFN-γ-induced type 11 nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 87: 344-352.
19. Gu, B., L. J. Bendall, and J. S. Wiley. 1998. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92: 946-951.
20. Labasi, J. M., N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, and C. A. Gabel. 2002. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol 168: 6436-6445.
21. Solle, M., J. Labasi, D. G. Perregaux, E. Stam, N. Petrushova, B. H. Koller, R. J. Griffiths, and C. A. Gabel. 2001. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276: 125-132.
22. Chessell, I. P., J. P. Hatcher, C. Bountra, A. D. Michel, J. P. Hughes, P. Green, J. Egerton, M. Murfin, J. Richardson, W. L. Peck, C. B. Giahames, M. A. Casula, Y. Yiangou, R. Birch, P. Anand, and G. N. Buell. 2005. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396.
23. Humphreys, B. D., J. Rice, S. B. Kertesy, and G. R. Dubyak. 2000. Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275: 26792-26798.
24. Brough, D., R. A. Le Feuvre, Y. Iwakura, and N. J. Rothwell. 2002. Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell. Neurosci. 19: 272-280.
25. + double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect. 5: 1363-1371.
26. Klapperstuck, M., C. Buttner, T. Bohm, G. Schmalzing, and F. Markwardt. 2000. Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes. Biochim. Biophys. Acta 1467: 444-456.
27. Wiley, J. S., C. E. Gargett, W. Zhang, M. B. Snook, and G. P. Jamieson. 1998. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am. J. Physiol. 275: C1224-C1231.
28. Seman, M., S. Adriouch, F. Scheuplein, C. Krebs, D. Freese, G. Glowacki, P. Deterre, F. Haag, and F. Koch-Nolte. 2003. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19: 571-582.
29. Kawamuia, H., F. Aswad, M. Minagawa, K. Malone, H. Kaslow, F. Koch-Nolte, W. H. Schott, E. H. Leiter, and G. Dennert. 2005. P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J. Immunol. 174: 1971-1979.
30. + regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J. Immunol. 175: 3075-3083.
31. Wekerle, H., K. Kojima, J. Lannes-Vieira, H. Lassmann, and C. Linington. 1994. Animal models. Ann. Neurol. 36(Suppl.): S47-S53.
32. Raine, C. S. 1994. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36(Suppl.): S61-S72.
33. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. 1L-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
34. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
35. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
36. Mannie, M. D., C. A. Dinarello, and P. Y. Paterson. 1987. Interleukin 1 and myclin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats. J. Immunol. 138: 4229-4235.
37. Probert, L., H. P. Eugster, K. Akassoglou, J. Bauer, K. Frei, H. Lassmann, and A. Fontana. 2000. TNFR1 signaling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123: 2005-2019.
38. Le Feuvre, R. A., D. Brough, Y. Iwakura, K. Takeda, and N. J. Rothwell. 2002. Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 277: 3210-3218.
39. Rajan, A. J., Y. L. Gao, C. S. Raine, and C. F. Brosnan. 1996. A pathogenic role for γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 157: 941-949.
40. Rivieccio, M. A., G. R. John, X. Song, H. S. Suh, Y. Zhao, S. C. Lee, and C. F. Brosnan. 2005. The cytokine IL-1β activates IFN response factor 3 in human fetal astrocytes in culture. J. Immunol. 174: 3719-3726.
41. Liu, J. S., M. L. Zhao, C. F. Brosnan, and S. C. Lee. 2001. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158: 2057-2066.
42. Le Feuvre, R., D. Brough, and N. Rothwell. 2002. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol. 447: 261-269.
43. Bonetti, B., J. Pohl, Y. L. Gao, and C. S. Raine. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159: 5733-5741.
44. Tabi, Z., P. A. McCombe, and M. P. Pender. 1995. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 7: 967-973.
45. Kahl, S., M. Nissen, R. Girisch, T. Duffy, E. H. Leiter, F. Haag, and F. Koch-Nolte. 2000. Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation. J. Immunol 165: 4463-4469.
46. Schiffenbauer, J., W. J. Streit, E. Butfiloski, M. LaBow, C. Edwards III, and L. L. Moldawer. 2000. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor, Clin. Immunol. 95: 117-123.
47. Ishihara, K., and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13: 357-368.
48. Wang, J., V. C. Asensio, and I. L. Campbell. 2002. Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. Curr. Top. Microbiol. Immunol. 265: 23-48.
49. Mason, J. L., K. Suzuki, D. D. Chaplin, and G. K. Matsushima. 2001. Interleukin-1β promotes repair of the CNS. J. Neurosci. 21: 7046-7052.
50. Penkowa, M., M. Giralt, N. Lago, J. Camats, J. Carrasco, J. Hernandez, A. Molinero, I. L. Campbell, and J. Hidalgo. 2003. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp. Neurol. 181: 130-148.
51. Swartz, K. R., F. Liu, D. Sewell, T. Schochet, I. Campbell, M, Sandor, and Z. Fabry. 2001. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896: 86-95.
52. Linker, R. A., M. Sendtner, and R. Gold. 2005. Mechanisms of axonal degeneration in EAE: lessons from CNTF and MHC I knockout mice. J. Neurol. Sci. 233: 167-172.
53. Suvannavejh, G. C., M. C. Dal Canto, L. A. Matis, and S. D. Miller. 2000. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105: 223-231.
54. Sabelko-Downes, K. A., A. H. Cross, and J. H. Russell. 1999. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189: 1195-1205.
55. Kohji, T., and Y. Matsumoto. 2000. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106: 165-171.
56. Okuda, Y., M. Okuda, and C. C. Bernard. 2003. Regulatory role of p53 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 135: 29-37.
57. Willenborg, D. O., S. A. Fordham, M. A. Staykova, I. A. Ramshaw, and W. B. Cowden. 1999. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163: 5278-5286.
58. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88: 1-8.
59. Willenborg, D. O., M. A. Staykova, and W. B. Cowden. 1999. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmunol. 100: 21-35.
60. Adriouch, S., C. Dos, V. Welge, M. Seman, F. Koch-Nolte, and F. Haag. 2002. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 169: 4108-4112.
61. Le Stunff, H., R. Auger, J. Kanellopoulos, and M. N. Raymond. 2004. The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J. Biol. Chem. 279: 16918-16926.
62. Cario-Toumaniantz, C., G. Loirand, L. Ferner, and P. Pacaud. 1998. Nongenomic Inhibition of human P2X7 purinoceptor by 17β-oestradiol. J. Physiol. 508: 659-666.
63. Wang, Q., X. Li, L. Wang, Y. H. Feng, R. Zeng, and G. Gorodeski. 2004. Antiapoptotic effects .of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145: 5568-5579.
64. Ke, H. Z., H. Qi, A. F. Weidema, Q. Zhang, N. Panupinthu, D. T. Crawford, W. A. Grasser, V. M. Paralkar, M. Li, L. P. Audoly, C. A. Gabel, W. S. Jee, S. J. Dixon, S. M. Sims, and D. D. Thompson. 2003. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol. 17: 1356-1367.
65. Okuda, Y., M. Okuda, and C. C. Bernard. 2002. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol. Lett. 81: 25-29.
66. Papenfuss, T. L., C. J. Rogers, I. Gienapp, M. Yurrita, M. McClain, N. Damico, J. Valo, F. Song, and C. C. Whitacre. 2004. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol. 150: 59-69.
67. Wotjak, C. T. 2003. C57BLack/BOX? The importance of exact mouse strain nomenclature. Trends Genet. 19: 183-184.
68. Gu, B. J., W. Zhang, R. A. Worthington, R. Sluyter, P. Dao-Ung, S. Petrou, J. A. Barden, and J. S. Wiley. 2001. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276: 11135-11142.
69. Wiley, J. S., L. P. Dao-Ung, C. Li, A. N. Shemon, B. J. Gu, M. L. Smart, S. J. Fuller, J. A. Barden, S. Petrou, and R. Sluyter. 2003. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J. Biol. Chem. 278: 17108-17113.
70. Denlinger, L. C., K. Schell, G. Angelini, D. Green, A. Guadarrama, U. Prabhu, D. B. Coursin, K. Hogan, and P. J. Bertics. 2004. A novel assay to detect nucleotide receptor P2X7 genetic polymorphisms influencing numerous innate immune functions. J Endotoxin Res. 10: 137-142.
71. Denlinger, L. C., G. Angelini, K. Schell, D. N. Green, A. G. Guadarrama, U. Prabhu, D. B. Coursin, P. J. Bertics, and K. Hogan. 2005. Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J. Immunol. 174: 4424-4431.
72. Wiley, J. S., L. P. Dao-Ung, B. J. Gu, R. Sluyter, A. N. Shemon, C. Li, J. Taper, J. Gallo, and A. Manoharan. 2002. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 359: 1114-1119.
73. Dao-Ung, L. P., S. J. Fuller, R. Sluyter, K. K. SkarRatt, U. Thunberg, G. Tobin, K. Byth, M. Ban, R. Rosenquist, G. J. Stewart, and J. S. Wiley. 2004. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. Br. J. Haematol. 125: 815-817.
74. Thunberg, U., G. Tobin, A. Johnson, O. Soderberg, L. Padyukov, M. Hultdin, L. Klareskog, G. Enblad, C. Sundstrom, G. Roos, and R. Rosenquist. 2002. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 360: 1935-1939.
75. Adinolfi, E., L. Melchiorri, S. Falzoni, P. Chiozzi, A. Morelli, A. Tieghi, A. Cuneo, G. Castoldi, F. Di Virgilio, and O. R. Baricordi. 2002. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99: 706-708.
76. Di Virgilio, F., and J. S. Wiley. 2002. The P2X7 receptor of CLL lymphocytes-a molecule with a split personality. Lancet 360: 1898-1899.